Related references
Note: Only part of the references are listed.Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter
Andrea Repaci et al.
ENDOCRINE PATHOLOGY (2022)
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
Alessandro Di Federico et al.
CANCERS (2022)
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience
Francesca Comito et al.
MELANOMA RESEARCH (2022)
Genomic profile of columnar cell variant of papillary thyroid carcinoma
Tyler Janovitz et al.
HISTOPATHOLOGY (2021)
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification
Giovanni Tallini et al.
CANCERS (2020)
BRAF Exon 15 Mutations in Papillary Carcinoma and Adjacent Thyroid Parenchyma: A Search for the Early Molecular Events Associated with Tumor Development
Giorgia Acquaviva et al.
CANCERS (2020)
Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel
Dario de Biase et al.
DIAGNOSTICS (2020)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium
Markus Luster et al.
THYROID (2019)
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
Giorgia Acquaviva et al.
HISTOPATHOLOGY (2018)
BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report
Elisabetta Macerola et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2017)
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Zhan Yao et al.
NATURE (2017)
The 2017 Bethesda System for Reporting Thyroid Cytopathology
Edmund S. Cibas et al.
THYROID (2017)
Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience
Liborio Torregrossa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAFK601E Mutation
Michelle Afkhami et al.
THYROID (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradigm Shift to Reduce Overtreatment of Indolent Tumors
Yuri E. Nikiforov et al.
JAMA ONCOLOGY (2016)
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study
Giovanni Tallini et al.
MODERN PATHOLOGY (2015)
High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
Noah A. Brown et al.
BLOOD (2014)
High-Sensitivity BRAF Mutation Analysis: BRAF V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary Thyroid Carcinomas
Dario de Biase et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinicopathological Features of Rare BRAF Mutations in Korean Thyroid Cancer Patients
Uiju Cho et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Clinicopathological relevance of BRAF mutations in human cancer
Sahar Pakneshan et al.
PATHOLOGY (2013)
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas
Nidhi Aggarwal et al.
MODERN PATHOLOGY (2012)
BRAF mutations in thyroid tumors from an ethnically diverse group
Hans-Juergen Schulten et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2012)
BRAFK601E Mutation in a Patient with a Follicular Thyroid Carcinoma
Gianmaria Pennelli et al.
THYROID (2011)
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness
V Trovisco et al.
VIRCHOWS ARCHIV (2005)
BRAF mutations are associated with some histological types of papillary thyroid carcinoma
V Trovisco et al.
JOURNAL OF PATHOLOGY (2004)
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas
J Lima et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma
KJ Rhoden et al.
LABORATORY INVESTIGATION (2004)
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
P Soares et al.
ONCOGENE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
